OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants
Andreas Wolff, Jörg Peine, Josef Höfler, et al.
CNS Drugs (2024) Vol. 38, Iss. 4, pp. 291-302
Open Access | Times Cited: 10
Andreas Wolff, Jörg Peine, Josef Höfler, et al.
CNS Drugs (2024) Vol. 38, Iss. 4, pp. 291-302
Open Access | Times Cited: 10
Showing 10 citing articles:
Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
Eun Hee Ahn, Jae‐Bong Park
Cells (2025) Vol. 14, Iss. 2, pp. 89-89
Open Access | Times Cited: 3
Eun Hee Ahn, Jae‐Bong Park
Cells (2025) Vol. 14, Iss. 2, pp. 89-89
Open Access | Times Cited: 3
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial
Jan Christoph Koch, Andreas Leha, Helen Bidner, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 11, pp. 1133-1146
Open Access | Times Cited: 6
Jan Christoph Koch, Andreas Leha, Helen Bidner, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 11, pp. 1133-1146
Open Access | Times Cited: 6
First-in-human study of CPL’116 – a dual JAK/ROCK inhibitor – in healthy subjects
Piotr J. Rudzki, Katarzyna Jarus‐Dziedzic, Dorota Włodarczyk, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Piotr J. Rudzki, Katarzyna Jarus‐Dziedzic, Dorota Włodarczyk, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Inhibition of contractility of isolated caprine detrusor by the rho kinase inhibitor fasudil and reversal by the guanylyl cyclase inhibitor ODQ
Niranjana Jeba Jeeviha, Aniket Kumar, Roshan Mathew, et al.
Current Therapeutic Research (2025), pp. 100795-100795
Open Access
Niranjana Jeba Jeeviha, Aniket Kumar, Roshan Mathew, et al.
Current Therapeutic Research (2025), pp. 100795-100795
Open Access
New insights on the regulators and inhibitors of RhoA-ROCK signalling in Parkinson’s disease
Nandita Ravichandran, Mahalaxmi Iyer, Deenathayalan Uvarajan, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Nandita Ravichandran, Mahalaxmi Iyer, Deenathayalan Uvarajan, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Role of RhoA-ROCK signaling inhibitor fasudil in Alzheimer disease
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Behavioural Brain Research (2025) Vol. 484, pp. 115524-115524
Closed Access
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Behavioural Brain Research (2025) Vol. 484, pp. 115524-115524
Closed Access
Exploring the Role of RhoA/ROCK Signaling in Pain: A Narrative Review
Nan Chen, Ye Tu, Dai-Qiang Liu, et al.
Aging and Disease (2025)
Open Access
Nan Chen, Ye Tu, Dai-Qiang Liu, et al.
Aging and Disease (2025)
Open Access
Fasudil mitigates diabetes-associated cognitive decline and enhances neuroprotection by suppressing NLRP3/Caspase-1/GSDMD signaling in a stroke mouse model
Mohd Salman, Hiba Shahzad, Rajashekhar Gangaraju, et al.
Experimental Neurology (2025) Vol. 389, pp. 115268-115268
Closed Access
Mohd Salman, Hiba Shahzad, Rajashekhar Gangaraju, et al.
Experimental Neurology (2025) Vol. 389, pp. 115268-115268
Closed Access
Emerging paradigms in Alzheimer's therapy
Agnes Preethy H., Kayalvizhi Rajendran, Anitha Josephine Sukumar, et al.
European Journal of Pharmacology (2024) Vol. 981, pp. 176872-176872
Closed Access | Times Cited: 1
Agnes Preethy H., Kayalvizhi Rajendran, Anitha Josephine Sukumar, et al.
European Journal of Pharmacology (2024) Vol. 981, pp. 176872-176872
Closed Access | Times Cited: 1
Differential Suppressive Effects of Rho Kinase Inhibitor Fasudil on Serotonin- and Noradrenaline-Induced Contractions of Human Internal Thoracic Arteries and Saphenous Veins
Takayuki Matsumoto, Takayuki Nagano, Atsuko Yokota, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 10, pp. 1657-1661
Open Access
Takayuki Matsumoto, Takayuki Nagano, Atsuko Yokota, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 10, pp. 1657-1661
Open Access
